Trial Profile
A study evaluating long term safety, tolerability and efficacy of Ustekinumab in patients with moderate-to-severe psoriasis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2017
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 08 Jun 2017 New trial record